Method and animal model for inducing bcc tumors
AssigneeFeldan Bio Inc.
InventorsNancy MESSIER, Frederic COUTURE
Life of this patent
Estimating the term…
Abstract
Methods for inducing basal cell carcinoma (BCC) or BCC tumors, as well as an inducible non-human animal models of BCC, are defined herein. The methods and animal models comprise targeting Ptch1 and/or a tumor suppressor gene via conditional expression of one or more short hairpin RNAs (shRNAs) in the skin of said animals.
Claims99
A genetically-modified non-human animal whose genome comprises one or more sequences encoding a short hairpin RNA (shRNA) targeting Ptch1, and a shRNA targeting p53 or other tumor suppressor genes, wherein expression or co-expression of said shRNAs is inducible and in the skin of said non-human animal.
A genetically-modified non-human animal whose genome comprises:
- an inducible cassette inserted into a genetic safe harbour site, wherein said cassette comprises:
- an upstream cleavable sequence that blocks expression of downstream sequences or genes;
- a first downstream sequence encoding a short hairpin RNA (shRNA) targeting Ptch1;
- and
- a second downstream sequence encoding a shRNA targeting p53;
- and
- a gene encoding a site-specific recombinase that cleaves the upstream cleavable sequence, wherein said gene is under the control of a skin cell-specific promoter and wherein expression of said gene is inducible.
A method of producing an inducible non-human animal, the method comprising:
- inserting an inducible cassette into a genetic safe harbour site, wherein said cassette comprises:
- an upstream cleavable sequence that blocks expression of downstream sequences or genes;
- a first downstream sequence encoding a short hairpin RNA (shRNA) targeting Ptch1;
- and
- a second downstream sequence encoding a shRNA targeting p53;
- and
- inserting into the genome of the non-human animal an inducible gene encoding a site-specific recombinase that cleaves the upstream cleavable sequence, wherein said gene is under the control of a skin cell-specific promoter.
A method for inducing basal cell carcinoma (BCC) or BCC tumor(s) in a non-human animal, the method comprising:
- providing a non-human animal whose genome comprises:
- an inducible cassette inserted into a genetic safe harbour site, wherein said cassette comprises:
- an upstream cleavable sequence that blocks expression of downstream sequences or genes;
- a first downstream sequence encoding a short hairpin RNA (shRNA) targeting Ptch1;
- and
- a second downstream sequence encoding a shRNA targeting p53;
- and
- a gene encoding a site-specific recombinase that cleaves the upstream cleavable sequence,
- wherein said gene is under the control of a skin cell-specific promoter and wherein expression of said gene is inducible;
- and
- administering a compound for inducing expression of the recombinase.
A cell comprising:
- an inducible cassette inserted into a genetic safe harbour site, wherein said cassette comprises:
- an upstream cleavable sequence that blocks expression of downstream sequences or genes;
- a first downstream sequence encoding a short hairpin RNA (shRNA) targeting Ptch1;
- and
- a second downstream sequence encoding a shRNA targeting p53;
- and
- a gene encoding a site-specific recombinase that cleaves the upstream cleavable sequence, wherein said gene is under the control of a skin cell-specific promoter and wherein expression of said gene is inducible.
A gene cassette or vector (e.g., plasmid) comprising:
- an upstream cleavable sequence that blocks expression of downstream sequences or genes;
- a first downstream sequence encoding a short hairpin RNA (shRNA) targeting Ptch1;
- and
- a second downstream sequence encoding a shRNA targeting p53.
A nucleotide sequence comprising:
- a sequence encoding inducible cassette inserted into a genetic safe harbour site, wherein said cassette comprises:
- an upstream cleavable sequence that blocks expression of downstream sequences or genes;
- a first downstream sequence encoding a short hairpin RNA (shRNA) targeting Ptch1;
- and
- a second downstream sequence encoding a shRNA targeting p53;
- and
- a sequence encoding a gene encoding a site-specific recombinase that cleaves the upstream cleavable sequence, wherein said gene is under the control of a skin cell-specific promoter and wherein expression of said gene is inducible.
A short hairpin RNA targeting Ptch1, said shRNA being encoded by a sequence having at least 50, 60, 70, 80, 90, 95, or 99% identity to the sequence of any one of SEQ ID NOs:
- 1-10.
A short hairpin RNA targeting Ptch1, said shRNA being encoded by the sequence of any one of SEQ ID NOs:
- 1-10.
A short hairpin RNA targeting Ptch1, said shRNA targeting a portion or region on SEQ ID NO:
- 12 that is at least 50, 60, 70, 80, 90, 95, 99%, or 100% identical to one or more of:
- (xi) Nucleobases 2776-2796 of SEQ ID NO:
- 12;
- (xii) Nucleobases 3601-3621 of SEQ ID NO:
- 12;
- (xiii) Nucleobases 442-462 of SEQ ID NO:
- 12;
- (xiv) Nucleobases 443-463 of SEQ ID NO:
- 12;
- (xv) Nucleobases 2526-2546 of SEQ ID NO:
- 12;
- (xvi) Nucleobases 1912-1933 of SEQ ID NO:
- 12;
- (xvii) Nucleobases 964-986 of SEQ ID NO:
- 12;
- (xviii) Nucleobases 2859-2880 of SEQ ID NO:
- 12;
- (xix) Nucleobases 2864-2884 of SEQ ID NO:
- 12;
- and
- (xx) Nucleobases 824-844 of SEQ ID NO:
- 12.
A genetically-modified non-human animal whose genome comprises:
- an inducible cassette inserted into a genetic safe harbour site, wherein said cassette comprises:
- an upstream cleavable sequence that blocks expression of downstream sequences or genes;
- a first downstream sequence encoding a short hairpin RNA (shRNA) targeting Ptch1;
- and
- a second downstream sequence encoding a shRNA targeting p53.
A cell comprising:
- an inducible cassette inserted into a genetic safe harbour site, wherein said cassette comprises:
- an upstream cleavable sequence that blocks expression of downstream sequences or genes;
- a first downstream sequence encoding a short hairpin RNA (shRNA) targeting Ptch1;
- and
- a second downstream sequence encoding a shRNA targeting p53.
Dependencies are inferred from the claim text.